Posts

Showing posts with the label metabolomics applications

Public and Private Funding Fuels the Demand for Metabolomics Global Market to Reach $6.3 billion by 2030

Image
The latest version of the report from Industry Experts, Inc., on " Metabolomics Market ", is published. As per this report, the global market for Metabolomics is estimated at US$3.1 billion in 2024 and is projected to reach US$6.3 billion by 2030, growing at a CAGR of 12.6%. Metabolomics market is witnessing rapid growth, fueled by significant funding from government and private sectors in research and development, alongside ongoing technological progress in analytical methods such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. The rising incidence of chronic illnesses, such as cancer, diabetes, cardiovascular, and neurological disorders, is driving demand for metabolomics. Metabolomics plays a crucial role in biomarker identification, enabling early disease detection and facilitating personalized treatment approaches. The efficacy biomarkers segment is anticipated to witness the fastest growth rate with a CAGR of 14.9% from 2024 to ...

Biomarkers and Drug Discovery to Drive Global Market for Metabolomics to reach $2.5 billion by 2020

Industry Experts has released the new market research report on metabolomics. The new global report ‘ Metabolomics: Technologies and Applications - A Global Market Overview ’ reveals that the global market for metabolomics is projected to touch US$2.5 billion from an estimated US$704 million in 2014, reflecting a robust 2014-2020 CAGR of 23.7%. In terms of metabolomics market by Therapeutic area, Oncology is expected to touch US4350 million mark in 2015 and maintain the largest disease area through to 2020. Large pharma companies have yet to take on a full-blown adoption of metabolomic technologies, when compared to proteomic and genomic research. This is because of the lingering uncertainties as to the advantages offered by metabolomics that have been the outcome of failed proteomics and genomics research programs. Through some recent accomplishments have been able to dispel some of these doubts, wider adoption and acceptance of metabolomics would necessitate additional landmark succ...